Imricor Medical Systems Inc. Stock Analysis IMR.AX

Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm develops MRI-compatible products for cardiac catheter ablation procedures. The Vision-MR Ablation Catheter is the Company’s prime product offering, specifically designed to work under real-time MRI guidance. Its other products include Advantage-MR EP Recorder/Stimulator System, the Vision-MR Diagnostic Catheter and Vision-MR Dispersive Electrode. Advantage-MR EP Recorder/Stimulator System provides technology that allows the physician to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The company sells its capital and consumable products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.